과제정보
This study was supported by the National Research Foundation of Korea (2019R1A2B5B03069677, 2020R1A4A2002903, and 2021R1C1C2004561).
참고문헌
- Kaelin WG Jr and Ratcliffe PJ (2008) Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell 30, 393-402 https://doi.org/10.1016/j.molcel.2008.04.009
- Bartoszewski R, Moszynska A, Serocki M et al (2019) Primary endothelial cell-specific regulation of hypoxia-inducible factor (HIF)-1 and HIF-2 and their target gene expression profiles during hypoxia. FASEB J 33, 7929-7941 https://doi.org/10.1096/fj.201802650rr
- Ginouves A, Ilc K, Macias N, Pouyssegur J and Berra E (2008) PHDs overactivation during chronic hypoxia "desensitizes" HIF alpha and protects cells from necrosis. Proc Natl Acad Sci U S A 105, 4745-4750 https://doi.org/10.1073/pnas.0705680105
- Kang J, Shin SH, Yoon H et al (2018) FIH is an oxygen sensor in ovarian cancer for G9a/GLP-driven epigenetic regulation of metastasis-related genes. Cancer Res 78, 1184-1199 https://doi.org/10.1158/0008-5472.CAN-17-2506
- Chakraborty AA, Laukka T, Myllykoski M et al (2019) Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate. Science 363, 1217 https://doi.org/10.1126/science.aaw1026
- Perez-Cadahia B, Drobic B and Davie JR (2009) H3 phosphorylation: dual role in mitosis and interphase. Biochem Cell Biol 87, 695-709 https://doi.org/10.1139/o09-053
- Baek SH (2011) When signaling kinases meet histones and histone modifiers in the nucleus. Mol Cell 42, 274-284 https://doi.org/10.1016/j.molcel.2011.03.022
- Willems E, Dedobbeleer M, Digregorio M, Lombard A, Lumapat PN and Rogister B (2018) The functional diversity of Aurora kinases: a comprehensive review. Cell Div 13, 7 https://doi.org/10.1186/s13008-018-0040-6
- Ooi L and Wood IC (2007) Chromatin crosstalk in development and disease: lessons from REST. Nat Rev Genet 8, 544-554 https://doi.org/10.1038/nrg2100
- Cavadas MAS, Mesnieres M, Crifo B et al (2016) REST is a hypoxia-responsive transcriptional repressor. Sci Rep 6, 31355 https://doi.org/10.1038/srep31355
- Hwang JY and Zukin RS (2018) REST, a master transcriptional regulator in neurodegenerative disease. Curr Opin Neurol 48, 193-200 https://doi.org/10.1016/j.conb.2017.12.008
- Cheong A, Bingham AJ, Li J et al (2005) Downregulated REST transcription factor is a switch enabling critical potassium channel expression and cell proliferation. Mol Cell 20, 45-52 https://doi.org/10.1016/j.molcel.2005.08.030
- Kuwahara K, Saito Y, Ogawa E et al (2001) The neuron-restrictive silencer element-neuron-restrictive silencer factor system regulates basal and endothelin 1-inducible atrial natriuretic peptide gene expression in ventricular myocytes. Mol Cell Biol 21, 2085-2097 https://doi.org/10.1128/MCB.21.6.2085-2097.2001
- Negrini S, Prada I, D'Alessandro R and Meldolesi J (2013) REST: an oncogene or a tumor suppressor? Trends Cell Biol 23, 289-295 https://doi.org/10.1016/j.tcb.2013.01.006
- Barrett TD, Palomino HL, Brondstetter TI et al (2011) Pharmacological characterization of 1-(5-chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic acid (JNJ42041935), a potent and selective hypoxia-inducible factor prolyl hydroxylase inhibitor. Mol Pharmacol 79, 910-920 https://doi.org/10.1124/mol.110.070508
- Chan MC, Ilott NE, Schodel J et al (2016) Tuning the transcriptional response to hypoxia by inhibiting hypoxiainducible factor (HIF) prolyl and asparaginyl hydroxylases. J Biol Chem 291, 20661-20673 https://doi.org/10.1074/jbc.M116.749291
- Frost J, Galdeano C, Soares P et al (2016) Potent and selective chemical probe of hypoxic signalling downstream of HIF-alpha hydroxylation via VHL inhibition. Nat Commun 7, 13312 https://doi.org/10.1038/ncomms13312
- Lim D, Do Y, Kwon BS et al (2020) Angiogenesis and vasculogenic mimicry as therapeutic targets in ovarian cancer. BMB Rep 53, 291-298 https://doi.org/10.5483/BMBRep.2020.53.6.060
- Manfredi JJ (2010) The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor. Genes Dev 24, 1580-1589 https://doi.org/10.1101/gad.1941710
- Fischer M (2017) Census and evaluation of p53 target genes. Oncogene 36, 3943-3956 https://doi.org/10.1038/onc.2016.502
- Kim I and Park JW (2020) Hypoxia-driven epigenetic regulation in cancer progression: a focus on histone methylation and its modifying enzymes. Cancer Lett 489, 41-49 https://doi.org/10.1016/j.canlet.2020.05.025
- Batie M, Frost J, Frost M, Wilson JW, Schofield P and Rocha S (2019) Hypoxia induces rapid changes to histone methylation and reprograms chromatin. Science 363, 1222 https://doi.org/10.1126/science.aau5870
- Hwang S, Kim S, Kim K, Yeom J, Park S and Kim I (2020) Euchromatin histone methyltransferase II (EHMT2) regulates the expression of ras-related GTP binding C (RRAGC) protein. BMB Rep 53, 576-581 https://doi.org/10.5483/BMBRep.2020.53.11.055
- Komar D and Juszczynski P (2020) Rebelled epigenome: histone H3S10 phosphorylation and H3S10 kinases in cancer biology and therapy. Clin Epigenetics 12, 147 https://doi.org/10.1186/s13148-020-00941-2
- Nie M, Wang YD, Yu ZN et al (2020) AURKB promotes gastric cancer progression via activation of CCND1 expression. Aging (Albany NY) 12, 1304-1321 https://doi.org/10.18632/aging.102684
- Biswas K, Sarkar S, Said N, Brautigan DL and Larner JM (2020) Aurora B kinase promotes CHIP-dependent degradation of HIF1 alpha in prostate cancer cells. Mol Cancer Ther 19, 1008-1017 https://doi.org/10.1158/1535-7163.mct-19-0777
- Klein AM, de Queiroz RM, Venkatesh D and Prives C (2021) The roles and regulation of MDM2 and MDMX: it is not just about p53. Genes Dev 35, 575-601 https://doi.org/10.1101/gad.347872.120
- Fahraeus R and Olivares-Illana V (2014) MDM2's social network. Oncogene 33, 4365-4376 https://doi.org/10.1038/onc.2013.410
- Zhang L and Hill RP (2004) Hypoxia enhances metastatic efficiency by up-regulating Mdm2 in KHT cells and increasing resistance to apoptosis. Cancer Res 64, 4180-4189 https://doi.org/10.1158/0008-5472.CAN-03-3038
- Shaikh MF, Morano WF, Lee J et al (2016) Emerging role of mdm2 as target for anti-cancer therapy: a review. Ann Clin Lab Sci 46, 627-634
- Nieminen AL, Qanungo S, Schneider EA, Jiang BH and Agani FH (2005) Mdm2 and HIF-1alpha interaction in tumor cells during hypoxia. J Cell Physiol 204, 364-369 https://doi.org/10.1002/jcp.20406
- Joshi S, Singh AR and Durden DL (2014) MDM2 regulates hypoxic hypoxia-inducible factor 1alpha stability in an E3 ligase, proteasome, and PTEN-phosphatidylinositol 3-kinaseAKT-dependent manner. J Biol Chem 289, 22785-22797 https://doi.org/10.1074/jbc.M114.587493
- Ravi R, Mookerjee B, Bhujwalla ZM et al (2000) Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev 14, 34-44 https://doi.org/10.1101/gad.14.1.34
- Kim HL, Yeo EJ, Chun YS and Park JW (2006) A domain responsible for HIF-1alpha degradation by YC-1, a novel anticancer agent. Int J Oncol 29, 255-260
- Kim I, Shin SH, Lee JE and Park JW (2019) Oxygen sensor FIH inhibits HACE1-dependent ubiquitination of Rac1 to enhance metastatic potential in breast cancer cells. Oncogene 38, 3651-3666 https://doi.org/10.1038/s41388-019-0676-y
- Chun YS, Choi E, Kim GT et al (2000) Zinc induces the accumulation of hypoxia-inducible factor (HIF)-1 alpha, but inhibits the nuclear translocation of HIF-1 beta, causing HIF-1 inactivation. Biochem Biophys Res Commun 268, 652-656 https://doi.org/10.1006/bbrc.2000.2180